The present invention relates to a hemodialysis filter and more particularly, the present invention relates to a hemodialysis filter rotator.
A hemodialysis device is generally used to clean the blood of patients who have a reduced kidney function or end stage renal disease (ESRD). The dialysis device principally consists of a filter consisting of a semi-permeable membrane, on one side of which passes blood and on the other side of which passes a dialysis solution. By designing the composition of the dialysis solution in a specific manner, an exchange of electrolytes across the semi-permeable membrane and reconditioning of the blood can thus take place.
Dialysis filters often clot and require extra saline flushes and/or anticoagulation drugs such as HEPARIN to prevent clotting. However, Heparin-free hemodialysis is usually obligatory in immediate post-operative states, bleeding diathesis, and in critically ill patients. Thus, there is a need to prevent clotting without extra saline flushes and/or anticoagulation drugs such as HEPARIN.
The foregoing and other problems are overcome, and other advantages are realized, in accordance with the presently preferred embodiments of these teachings.
A hemodialysis filter rotator is provided. Included is a programmable motor controller; a hemodialysis filter holder; and a rotating motor connected to the hemodialysis filter holder, wherein the programmable motor controller rotates the hemodialysis filter holder according to a predetermined program.
The rotating motor rotates a hemodialysis filter, such as a CAR-170-C NXSTAGE Chronic Cartridge Hemodialysis Filter, for example. The programmable rotation of the filter prevents clotting of the hemodialysis extracorporeal system. Thus, enabling the consistent hemodialysis treatments whether at home or in the hospital without the need for anticoagulation with drugs such as HEPARIN; enabling the patient with end stage renal disease to undergo HEPARIN-free hemodialysis whether at home or in the hospital. By avoiding the use of HEPARIN, hemodialysis can be more safely carried out in very sick patients, in patients with bleeding diathesis, in patients immediately following surgical operations and in patients where the use of HEPARIN is contraindicated. Furthermore, the avoidance of HEPARIN results in cost savings and the avoidance of any other potential adverse effects of HEPARIN such as bleeding, thrombocytopenia, and other hypersensitivity reactions.
The subject matter which is regarded as the invention is particularly pointed out and distinctly claimed in the claims at the conclusion of the specification. The foregoing and other objects, features, and advantages of the invention are apparent from the following detailed description taken in conjunction with the accompanying drawings in which:
The following brief definition of terms shall apply throughout the application:
The term “comprising” means including but not limited to, and should be interpreted in the manner it is typically used in the patent context;
The phrases “in one embodiment,” “according to one embodiment,” and the like generally mean that the particular feature, structure, or characteristic following the phrase may be included in at least one embodiment of the present invention, and may be included in more than one embodiment of the present invention (importantly, such phrases do not necessarily refer to the same embodiment);
If the specification describes something as “exemplary” or an “example,” it should be understood that refers to a non-exclusive example; and
If the specification states a component or feature “may,” “can,” “could,” “should,” “preferably,” “possibly,” “typically,” “optionally,” “for example,” or “might” (or other such language) be included or have a characteristic, that particular component or feature is not required to be included or to have the characteristic.
Referring to
The holder 2 comprises an engagement device 8 which cooperates with, and holds, the dialysis filter approximately at its middle. The engagement device 8 is provided with a rod 9 which is inserted into a horizontal hole 10 in a miniaturized motor 11 in the side of the dialysis machine. The rod 9 is maintained within the hole 10 with the aid of a screw 12.
The dialysis machine 1 is provided with a drain 13 for dialysate solution and an inlet 14 for dialysate solution. The outlet 13 and the inlet 14 are provided with tubes, 15 and 16, which, in the stand-by position, are coupled to separate bypass couplings, 17, 18 and 19, positioned on the front of the dialysis machine.
For priming, sterile physiological common salt solution is fed through the dialysis filter from below by means of the tube 5 and out through tube 4 so that all of the air is forced out from the spaces within the hollow fibers. At the same time, dialysate solution is supplied through inlet 6 and out through the outlet 7 in countercurrent flow.
Still referring to
An 87-yo white male with ESRD and atrial fibrillation on Coumadin, on maintenance Home Hemodialysis (HHD) with a NxStage machine, underwent laparoscopic appendicectomy. This was complicated by intra-abdominal abscess, sepsis, and tamponade from a bloody pericardial effusion. He needed emergent therapeutic pericardiocentesis. Coumadin was promptly discontinued. He was discharged home on HEPARIN-free HHD. HHD was complicated by recurrent clotting of the extracorporeal system despite massive quantities of saline flushes. It was observed that the horizontally placed CAR-170-C NXSTAGE Chronic cartridge (hemodialysis filter) exhibited early “clot” formation at the 12 o'clock spot, despite the repeated large-volume normal saline flushes. It was observed that blood was pooling around this site and that the first signs of clotting was appearing here. Through multiple and staggered physical manipulations and maneuvers of the HD filter, it was collaboratively confirmed: Rotating the horizontally placed HD filter along its long axis, 60 degrees clockwise ×15 minutes, return to the neutral position ×15 minutes, followed by rotating the filter another 60 degrees counterclockwise ×15 minutes, and then a return to the neutral position ×15 minutes had promptly and consistently resolved the clotting problem. These rotating steps are simultaneously continued throughout the HHD treatment. The extracorporeal system and HD filter had stopped clotting and for over seven months now, the patient has not needed normal saline flushes for smooth anticoagulation-free HHD. This transition occurred in December 2019 and since January 2020, the HHD runs have been generally smooth and uneventful (
It will be appreciated that the to-and-fro, back-and-forth, clockwise, then counterclockwise alternating rotational movements of the horizontally placed hemodialysis filter produced antigravity effects that it was able to maintain fluidity of the blood in the hemodialysis filter 3 capillaries thus enabling consistent and successful completion of anticoagulation-free frequent home hemodialysis in subject patient over the past 10 months at a frequency of 4 hemodialysis treatments a week. The anti-gravity effects along the long axis of the cartridge, provide physical defense against progressive clotting of the filter fibers.
It should be understood that the foregoing description is only illustrative of the invention. Thus, various alternatives and modifications can be devised by those skilled in the art without departing from the invention. Accordingly, the present invention is intended to embrace all such alternatives, modifications and variances that fall within the scope of the appended claims.
The present application is related to, claims the earliest available effective filing date(s) from (e.g., claims earliest available priority dates for other than provisional patent applications; claims benefits under 35 USC § 119(e) for provisional patent applications), and incorporates by reference in its entirety all subject matter of the following listed application(s) (the “Related Applications”) to the extent such subject matter is not inconsistent herewith; the present application also claims the earliest available effective filing date(s) from, and also incorporates by reference in its entirety all subject matter of any and all parent, grandparent, great-grandparent, etc. applications of the Related Application(s) to the extent such subject matter is not inconsistent herewith: U.S. provisional patent application 63/094,958 entitled “Hemodialysis Filter Rotator”, naming Macaulay Onuigbo as first inventor, filed 22 Oct. 2020.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2021/056146 | 10/22/2021 | WO |
Number | Date | Country | |
---|---|---|---|
63094958 | Oct 2020 | US |